Clinical Trial Update: The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial assessing Tang Ning Tongluo Formula in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tang Ning Tongluo Formula

Snippet

Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd | Conditions: General Disorders and Administration Site Conditions | Phase 2 | Status: COMPLETED